Clinical trial
Evaluation of the Efficacy and Safety of Silodosin in the Treatment of the Signs…
NCT00359905 · RECORDATI GROUP, Industry · Completed
Key facts
| NCT number | NCT00359905 |
|---|---|
| Title | Evaluation of the Efficacy and Safety of Silodosin in the Treatment of the Signs and Symptoms of BPH |
| Official title | Evaluation of the Efficacy and Safety of Silodosin vs. Tamsulosin and Placebo in the Treatment of the Signs and Symptoms of BPH. Multicentre, Randomised, Double-Blind, Controlled Trial With an Optional Long-Term, Open-Label Extension Phase. |
| Lead sponsor | RECORDATI GROUP, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Benign Prostatic Hyperplasia |
| Intervention type | Drug |
| Interventions | Silodosin, Tamsulosin, Placebo |
| Enrollment | 1,228 |
| Start date | May 1, 2006 |
| Primary completion | May 1, 2007 |
| Completion | Jan 1, 2008 |
| First posted | Aug 3, 2006 |
| Last update posted | Feb 19, 2009 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: